106 related articles for article (PubMed ID: 8206274)
1. A novel matrix-degrading protease in hormone-dependent breast cancer.
Dickson RB; Shi YE; Johnson MD
Biochem Soc Trans; 1994 Feb; 22(1):49-52. PubMed ID: 8206274
[No Abstract] [Full Text] [Related]
2. Stromal cell expression of components of matrix-degrading protease systems in human cancer.
Hewitt R; Danø K
Enzyme Protein; 1996; 49(1-3):163-73. PubMed ID: 8797004
[TBL] [Abstract][Full Text] [Related]
3. Assay of matrix metalloproteinases types 1, 2, 3 and 9 in breast cancer.
Remacle AG; Noël A; Duggan C; McDermott E; O'Higgins N; Foidart JM; Duffy MJ
Br J Cancer; 1998 Mar; 77(6):926-31. PubMed ID: 9528836
[TBL] [Abstract][Full Text] [Related]
4. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases.
Butler GS; Will H; Atkinson SJ; Murphy G
Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036
[TBL] [Abstract][Full Text] [Related]
5. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
7. Increased matrix metalloproteinase-2 activity induced by TGF-beta 1 in duct cells of human salivary gland is associated with the development of cyst formation in vivo.
Azuma M; Tamatani T; Yuki T; Motegl K; Hoque MO; Yoshida H; Sato M
J Oral Pathol Med; 1996 Oct; 25(9):467-73. PubMed ID: 8959553
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases in bronchoalveolar lavage fluid following antigen challenge.
Warner JA; Julius P; Luttmann W; Kroegel C
Int Arch Allergy Immunol; 1997; 113(1-3):318-20. PubMed ID: 9130563
[No Abstract] [Full Text] [Related]
9. Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression.
Lee KS; Rha SY; Kim SJ; Kim JH; Roh JK; Kim BS; Chung HC
Clin Exp Metastasis; 1996 Nov; 14(6):512-9. PubMed ID: 8970581
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Kossakowska AE; Huchcroft SA; Urbanski SJ; Edwards DR
Br J Cancer; 1996 Jun; 73(11):1401-8. PubMed ID: 8645587
[TBL] [Abstract][Full Text] [Related]
11. The binding of gelatinases A and B to type I collagen yields both high and low affinity sites.
Allan JA; Docherty AJ; Murphy G
Ann N Y Acad Sci; 1994 Sep; 732():365-6. PubMed ID: 7978809
[No Abstract] [Full Text] [Related]
12. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
[TBL] [Abstract][Full Text] [Related]
13. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.
Nuovo GJ; MacConnell PB; Simsir A; Valea F; French DL
Cancer Res; 1995 Jan; 55(2):267-75. PubMed ID: 7812956
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase and tissue inhibitor of metalloproteinase regulation of the invasive potential of a metastatic renal cell line.
McElligott AM; Baker AH; McGlynn H
Biochem Soc Trans; 1997 Feb; 25(1):147S. PubMed ID: 9057045
[No Abstract] [Full Text] [Related]
15. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
[TBL] [Abstract][Full Text] [Related]
16. Host expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in normal colon tissue affects metastatic potential of colorectal cancer.
Masuda H; Aoki H
Dis Colon Rectum; 1999 Mar; 42(3):393-7. PubMed ID: 10223763
[TBL] [Abstract][Full Text] [Related]
17. Coordinate enhancement of gelatinase A mRNA and activity levels in human fibroblasts in response to breast-adenocarcinoma cells.
Noël AC; Polette M; Lewalle JM; Munaut C; Emonard HP; Birembaut P; Foidart JM
Int J Cancer; 1994 Feb; 56(3):331-6. PubMed ID: 8314319
[TBL] [Abstract][Full Text] [Related]
18. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis.
Hembry RM; Bagga MR; Reynolds JJ; Hamblen DL
Ann Rheum Dis; 1995 Jan; 54(1):25-32. PubMed ID: 7880117
[TBL] [Abstract][Full Text] [Related]
19. Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.
Torii K; Iida K; Miyazaki Y; Saga S; Kondoh Y; Taniguchi H; Taki F; Takagi K; Matsuyama M; Suzuki R
Am J Respir Crit Care Med; 1997 Jan; 155(1):43-6. PubMed ID: 9001287
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of matrix metalloproteinase-2 activation in human breast cancer cell lines.
Maiti SN; Yu M; Bueno J; Tirgari RH; Palao-Marco FL; Pulyaeva H; Thompson EW
Ann N Y Acad Sci; 1994 Sep; 732():456-8. PubMed ID: 7978838
[No Abstract] [Full Text] [Related]
[Next] [New Search]
